Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-121,547
Closed -$1.87M 187
2023
Q3
$1.87M Buy
121,547
+5,145
+4% +$85K 0.08% 129
2023
Q2
$1.99M Sell
116,402
-15,128
-12% -$252K 0.1% 117
2023
Q1
$2.13M Buy
131,530
+3,242
+3% +$56.1K 0.12% 119
2022
Q4
$2.15M Sell
128,288
-6,852
-5% -$115K 0.15% 121
2022
Q3
$1.91M Buy
135,140
+68,950
+104% +$1.01M 0.16% 122
2022
Q2
$1M Sell
66,190
-11,879
-15% -$200K 0.07% 137
2022
Q1
$1.15M Buy
78,069
+1,186
+2% +$19.9K 0.12% 131
2021
Q4
$1.15M Buy
76,883
+22,344
+41% +$359K 0.25% 105
2021
Q3
$843K Buy
54,539
+38,815
+247% +$658K 0.27% 92
2021
Q2
$278K Buy
+15,724
New +$281K 0.07% 106

Other funds holding FONR

Invenomic Capital Management's FONR Position: Q4 2023 in Review

Invenomic Capital Management sold out of Fonar (FONR) in Q4 2023, closing a stake of 121,547 shares — an estimated $1.87M sold.

Invenomic Capital Management first reported a position in FONR in Q2 2021 and held it in 10 quarters. The position peaked at $2.15M in Q4 2022. 51 funds tracked by Wall St. Rank hold FONR as of Q4 2023.

  • Invenomic Capital Management reported no remaining Fonar position as of Q4 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 121,547 Fonar shares in Q4 2023, an estimated $1.87M.
  • Invenomic Capital Management first reported a position in Fonar in Q2 2021 and held it in 10 quarters.
  • Invenomic Capital Management's Fonar position peaked at $2.15M in Q4 2022.
  • 51 funds tracked by Wall St. Rank held Fonar as of Q4 2023.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.